Tag Archives: JNJ

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (NYSE: JNJ), Bluebird Bio (NASDAQ: BLUE) and BioMarin Pharmaceutical (NASDAQ: BMRN)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Johnson & Johnson (JNJ – Research Report), Bluebird Bio (BLUE – Research Report) and BioMarin Pharmaceutical (BMRN – Research Report) with bullish

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (NYSE: JNJ) and Sanofi (Other OTC: SNYNF)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Johnson & Johnson (JNJ – Research Report) and Sanofi (SNYNF – Research Report) with bullish sentiments. Johnson & Johnson (JNJ) Credit Suisse

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (NYSE: JNJ) and Ionis Pharmaceuticals (NASDAQ: IONS)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Johnson & Johnson (JNJ – Research Report) and Ionis Pharmaceuticals (IONS – Research Report). Johnson & Johnson (JNJ) In a report issued on February 13,

Credit Suisse Maintains a Buy Rating on Johnson & Johnson (JNJ)

In a report issued on May 17, Matt Miksic from Credit Suisse maintained a Buy rating on Johnson & Johnson (JNJ – Research Report). The company’s shares closed last Thursday at $147.19. According to TipRanks.com, Miksic is a 5-star analyst

Credit Suisse Believes Johnson & Johnson (NYSE: JNJ) Still Has Room to Grow

Credit Suisse analyst Matt Miksic maintained a Buy rating on Johnson & Johnson (JNJ – Research Report) on August 23. The company’s shares closed last Thursday at $149.55, close to its 52-week high of $157.00. According to TipRanks.com, Miksic is

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (NYSE: JNJ) and Pacira Pharmaceuticals (NASDAQ: PCRX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Johnson & Johnson (JNJ – Research Report) and Pacira Pharmaceuticals (PCRX – Research Report) with bullish sentiments. Johnson & Johnson (JNJ) In